Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$21.71M$21.71Mderived+23.6% vs Q4 2018 Net Income$805.00K$805.00KderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$12,947,000+29.8% Operating Incomederived$1,311,000+940.5% Operating Cash Flowderived$4,341,000+36.5% Free Cash Flowderived$2,830,000−61.9% Margins · derivedGross margin59.6%+2.9 pt vs Q4 2018
Operating margin6.0%+5.3 pt vs Q4 2018
Net margin3.7%+5.3 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end